Skip to content
healthcare.dev

Ultramicrosize Griseofulvin

NDC 23155-863, Griseofulvin, tablet, from Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc.

Product NDC
23155-863
Status
Listed
Labeler
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA061996
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/23155-863 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GRISEOFULVIN125 mg/1

Pharmacologic classes

Decreased Mitosis [PE]; Microtubule Inhibition [PE]; Tubulin Inhibiting Agent [EPC]

Package NDCNDC-11Package
23155-863-0123155086301100 TABLET in 1 BOTTLE, PLASTIC (23155-863-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ae369582-2e4c-48a4-ac42-0a77466654fd
  • NADAC price for package 23155086301

    GET /v1/drugs/nadac/23155086301

Use it

Look up 23155-863 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/23155-863 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 23155-863. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.